Aisha Noor

Analyst

Morgan Stanley

Equibles does not estimate personal net worth.

About Aisha Noor

Aisha Noor is recorded as Analyst at Morgan Stanley. Aisha Noor has spoken on 4 earnings calls and 2 other investor events across 4 companies, most recently for BIOMERIEUX SA on November 3, 2026. Those appearances were for Koninklijke Philips NV (PHG), Qiagen N.V. (QGEN), BIOMERIEUX SA and Bruker Corp (BRKR). The companies whose calls Aisha Noor spoke on are classified in the Healthcare sector.

Aisha Noor on recent calls

“My first one is on the respiratory season. So, your competitor has cautiously called out a double-digit decline in respiratory sales for Q4 and flat growth in 2027 due to CDC flu data not picking up that much in recent weeks.”

Analyst — Morgan Stanley, bioMérieux Q3 2026 Results · November 3, 2026

“Just one left from my side, and it's on the order development in connected care.”

Analyst — Morgan Stanley, Q3 FY2026 Earnings conference call (announced in 6-K) · November 3, 2026

“All right, welcome everyone to our fireside chat with KIAGEN. I'm Aisha Noor, Head of European MedTech Research at Morgan Stanley. It's my pleasure to host KIAGEN CEO Jonathan Pratt and CFO Roland Sackers today, as well as IR Domenica Mortarana.”

Host, Morgan Stanley Healthcare Conference · September 14, 2026

“My question is just on D&T and your competitive outlook in Europe following the launch of an ultrasound by United Imaging in the space and as well on the recent launch of Verita for you, just how that's progressing and how we should be thinking about the sales contribution for 2026.”

Analyst — Morgan Stanley, Koninklijke Philips NV Q1 FY2026 Earnings Call · May 6, 2026

“Could you unpack the 3% organic growth a little bit, so instruments versus consumables, U.S. versus Europe, and could this accelerate further to a mid-single-digit type of organic growth in the second half?”

Analyst — Morgan Stanley, Earnings conference call (announced in 6-K) · April 28, 2026